Literature DB >> 2256749

Antenatal administration of aminopropylidene diphosphonate.

D J Dunlop, M Soukop, H P McEwan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2256749      PMCID： PMC1004276          DOI： 10.1136/ard.49.11.955-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

1.  Effect of single high dose infusions of aminohydroxypropylidene diphosphonate on hypercalcaemia caused by cancer.

Authors:  B M Cantwell; A L Harris
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-21

2.  Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.

Authors:  S H Ralston; M D Gardner; F J Dryburgh; A S Jenkins; R A Cowan; I T Boyle
Journal:  Lancet       Date:  1985-10-26       Impact factor: 79.321

3.  Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia.

Authors:  H P Sleeboom; O L Bijvoet; A T van Oosterom; J H Gleed; J L O'Riordan
Journal:  Lancet       Date:  1983-07-30       Impact factor: 79.321
  3 in total
  9 in total

Review 1.  Osteoporosis in juvenile idiopathic arthritis--a practical approach to diagnosis and therapy.

Authors:  Johannes Roth; Susanne Bechtold; Gudrun Borte; Frank Dressler; Hermann J Girschick; Michael Borte
Journal:  Eur J Pediatr       Date:  2007-04-14       Impact factor: 3.183

2.  Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study.

Authors:  A Sokal; E Elefant; T Leturcq; D Beghin; X Mariette; R Seror
Journal:  Osteoporos Int       Date:  2018-08-31       Impact factor: 4.507

Review 3.  Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.

Authors:  Yujuan Zhang; Diana Milojevic
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

4.  Chemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists.

Authors:  Sophie E McGrath; Alistair Ring
Journal:  Ther Adv Med Oncol       Date:  2011-03       Impact factor: 8.168

5.  Pamidronate Administration During Pregnancy and Lactation Induces Temporal Preservation of Maternal Bone Mass in a Mouse Model of Osteogenesis Imperfecta.

Authors:  Diana Olvera; Rachel Stolzenfeld; Emily Fisher; Bonnie Nolan; Michelle S Caird; Kenneth M Kozloff
Journal:  J Bone Miner Res       Date:  2019-10-09       Impact factor: 6.741

Review 6.  Taking bisphosphonates during pregnancy.

Authors:  Amy E French; Nikolay Kaplan; Michael Lishner; Gideon Koren
Journal:  Can Fam Physician       Date:  2003-10       Impact factor: 3.275

7.  [Diagnosis, prophylaxis and therapy of osteoporosis in juvenile idiopathic arthritis: consensus statement of the German Association for Pediatric Rheumatology].

Authors:  J Roth; S Bechtold; G Borte; F Dressler; H Girschick; M Borte
Journal:  Z Rheumatol       Date:  2007-09       Impact factor: 1.372

Review 8.  The role of bisphosphonates in diseases of childhood.

Authors:  Tarak Srivastava; Uri S Alon
Journal:  Eur J Pediatr       Date:  2003-09-11       Impact factor: 3.183

9.  Anti-inflammatory and immunosuppressive drugs and reproduction.

Authors:  Monika Østensen; Munther Khamashta; Michael Lockshin; Ann Parke; Antonio Brucato; Howard Carp; Andrea Doria; Raj Rai; Pierluigi Meroni; Irene Cetin; Ronald Derksen; Ware Branch; Mario Motta; Caroline Gordon; Guillermo Ruiz-Irastorza; Arsenio Spinillo; Deborah Friedman; Rolando Cimaz; Andrew Czeizel; Jean Charles Piette; Ricard Cervera; Roger A Levy; Maurizio Clementi; Sara De Carolis; Michelle Petri; Yehuda Shoenfeld; David Faden; Guido Valesini; Angela Tincani
Journal:  Arthritis Res Ther       Date:  2006-05-11       Impact factor: 5.156
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.